Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters.
President Joe Biden says people who have been waiting for the FDA to formally approve a COVID-19 vaccine should get their shot now to stem what he calls a “pandemic of the unvaccinated.” Dr. Michael Angarone of Northwestern Medicine weighs in on that and more.
The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that could boost public confidence in the shots and spur more companies, universities and local governments to make vaccinations mandatory.
Just because Pfizer wants to offer COVID-19 vaccine boosters doesn’t mean people will be lining up anytime soon — U.S. and international health authorities say that for now, the fully vaccinated seem well protected.
Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden’s chief medical adviser acknowledged that “it is entirely conceivable, maybe likely” that booster shots will be needed.
U.S. regulators on Monday expanded the use of Pfizer’s COVID-19 vaccine to children as young as 12, offering a way to protect the nation’s adolescents before they head back to school in the fall and paving the way for them to return to more normal activities.
Pfizer’s vaccine is authorized for ages 16 and older. Vaccinating children of all ages will be critical to stopping the pandemic — and helping schools, at least the upper grades, start to look a little more normal after months of disruption.
The biggest vaccination campaign in U.S. history kicked off Monday as health workers rolled up their sleeves for shots to protect them from COVID-19 and start beating back the pandemic — a day of optimism even as the nation’s death toll closed in on 300,000.
The first of many freezer-packed COVID-19 vaccine vials made their way to distribution sites across the United States on Sunday, as the nation’s pandemic deaths approached the horrifying new milestone of 300,000.
The nation’s first COVID-19 vaccine will begin arriving in states Monday morning, U.S. officials said Saturday, after the government gave the final go-ahead to the shots needed to end an outbreak that has killed nearly 300,000 Americans.
The U.S. gave the final go-ahead Friday to the nation’s first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak that has killed nearly 300,000 Americans.
Pfizer’s COVID-19 vaccines are expected to ship to Illinois and the rest of the country as soon as this weekend, with much of that shipment being stored in Pleasant Prairie, Wisconsin.
FDA advisory committee to hold public meeting Thursday about Pfizer’s coronavirus vaccine.
The FDA’s vaccine advisory committee is preparing to meet Thursday to discuss Pfizer’s vaccine. Dr. Archana Chatterjee, dean of the Chicago Medical School and a member of that committee, talks about that process.
In giving the go-ahead for emergency use of the vaccine developed by American drugmaker Pfizer and Germany’s BioNTech, Britain vaulted past the United States by at least a week.
The first doses of a COVID-19 vaccine could be administered to health care workers in Chicago in three weeks, Chicago health officials said Tuesday.
The announcement came less than a week after an election seen as a referendum on President Donald Trump’s handling of the scourge, which has killed more than 1.2 million people worldwide.